Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AXGN NASDAQ:ESTA NASDAQ:LMAT NASDAQ:TCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAXGNAxoGen$42.71+0.8%$39.14$9.22▼$45.83$2.28B1.121.01 million shs416,199 shsESTAEstablishment Labs$82.17-3.5%$68.34$33.35▼$86.00$2.42B1.11508,337 shs236,014 shsLMATLeMaitre Vascular$92.38+0.0%$104.42$79.00▼$118.01$2.11B0.54231,167 shs82,956 shsTCMDTactile Systems Technology$26.36+0.0%$24.64$9.41▼$37.77$595.81M0.83325,570 shs33,251 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAXGNAxoGen+2.47%-0.07%+3.49%+30.98%+316.52%ESTAEstablishment Labs+7.11%+11.27%+23.03%+34.35%+120.84%LMATLeMaitre Vascular0.00%-0.83%-5.02%-14.55%+11.07%TCMDTactile Systems Technology+1.46%+4.69%+11.98%-2.15%+162.71%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAXGNAxoGen$42.71+0.8%$39.14$9.22▼$45.83$2.28B1.121.01 million shs416,199 shsESTAEstablishment Labs$82.17-3.5%$68.34$33.35▼$86.00$2.42B1.11508,337 shs236,014 shsLMATLeMaitre Vascular$92.38+0.0%$104.42$79.00▼$118.01$2.11B0.54231,167 shs82,956 shsTCMDTactile Systems Technology$26.36+0.0%$24.64$9.41▼$37.77$595.81M0.83325,570 shs33,251 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAXGNAxoGen+2.47%-0.07%+3.49%+30.98%+316.52%ESTAEstablishment Labs+7.11%+11.27%+23.03%+34.35%+120.84%LMATLeMaitre Vascular0.00%-0.83%-5.02%-14.55%+11.07%TCMDTactile Systems Technology+1.46%+4.69%+11.98%-2.15%+162.71%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAXGNAxoGen 2.73Moderate Buy$46.508.87% UpsideESTAEstablishment Labs 2.67Moderate Buy$87.146.06% UpsideLMATLeMaitre Vascular 2.75Moderate Buy$112.6021.89% UpsideTCMDTactile Systems Technology 2.86Moderate Buy$38.6046.43% UpsideCurrent Analyst Ratings BreakdownLatest TCMD, ESTA, AXGN, and LMAT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/8/2026ESTAEstablishment Labs TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/3/2026LMATLeMaitre Vascular Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$120.005/29/2026AXGNAxoGen Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/29/2026AXGNAxoGen Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold5/21/2026TCMDTactile Systems Technology BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$40.005/20/2026LMATLeMaitre Vascular Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeBuy (B-) ➝ Buy (B)5/7/2026ESTAEstablishment Labs BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$88.00 ➝ $90.005/7/2026TCMDTactile Systems Technology B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy$32.00 ➝ $36.005/6/2026LMATLeMaitre Vascular Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)5/6/2026TCMDTactile Systems Technology Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C+) ➝ Hold (C-)5/6/2026ESTAEstablishment Labs CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral(Data available from 6/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAXGNAxoGen$225.21M10.09N/AN/A$2.79 per share15.31ESTAEstablishment Labs$211.08M11.46N/AN/A$0.81 per share101.44LMATLeMaitre Vascular$256.28M8.24$2.90 per share31.82$17.35 per share5.32TCMDTactile Systems Technology$329.52M1.80$1.17 per share22.55$9.80 per share2.69Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAXGNAxoGen-$15.70M-$0.64N/A158.19N/A-13.21%-9.63%-6.26%8/4/2026 (Estimated)ESTAEstablishment Labs-$51.06M-$1.49N/A586.90N/A-19.05%-218.77%-12.31%8/6/2026 (Estimated)LMATLeMaitre Vascular$57.73M$2.7134.0928.252.5724.35%15.36%9.78%8/4/2026 (Estimated)TCMDTactile Systems Technology$19.09M$0.8830.0118.18N/A5.91%9.70%7.53%8/3/2026 (Estimated)Latest TCMD, ESTA, AXGN, and LMAT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026ESTAEstablishment Labs-$0.3550-$0.45-$0.0951-$0.45$57.40 million$59.88 million5/5/2026Q1 2026LMATLeMaitre Vascular$0.66$0.68+$0.02$0.68$66.67 million$66.55 million5/4/2026Q1 2026TCMDTactile Systems Technology-$0.07-$0.08-$0.01-$0.08$70.57 million$75.27 million4/28/2026Q1 2026AXGNAxoGen$0.12$0.07-$0.05-$0.38$57.85 million$61.46 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAXGNAxoGenN/AN/AN/AN/AN/AESTAEstablishment LabsN/AN/AN/AN/AN/ALMATLeMaitre Vascular$1.001.08%+16.05%36.90%14 YearsTCMDTactile Systems TechnologyN/AN/AN/AN/AN/ALatest TCMD, ESTA, AXGN, and LMAT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/28/2026LMATLeMaitre Vascularquarterly$0.251%5/21/20265/21/20266/4/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAXGNAxoGen0.087.105.33ESTAEstablishment Labs16.822.961.91LMATLeMaitre Vascular0.4214.3212.20TCMDTactile Systems TechnologyN/A4.243.78Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAXGNAxoGen80.29%ESTAEstablishment Labs72.91%LMATLeMaitre Vascular84.64%TCMDTactile Systems Technology83.43%Insider OwnershipCompanyInsider OwnershipAXGNAxoGen2.44%ESTAEstablishment Labs9.99%LMATLeMaitre Vascular7.40%TCMDTactile Systems Technology2.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAXGNAxoGen45053.18 million51.88 millionOptionableESTAEstablishment Labs1,00429.43 million26.49 millionOptionableLMATLeMaitre Vascular49022.85 million21.16 millionOptionableTCMDTactile Systems Technology1,08622.56 million22.08 millionOptionableTCMD, ESTA, AXGN, and LMAT HeadlinesRecent News About These CompaniesTactile Systems Technology (NASDAQ:TCMD) versus Integer (NYSE:ITGR) Financial ReviewJune 9 at 4:08 AM | americanbankingnews.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Rating of "Moderate Buy" from BrokeragesJune 3, 2026 | americanbankingnews.comTactile Medical Launches Next-Generation AffloVest® Airway Clearance TherapyJune 2, 2026 | globenewswire.comTactile Systems Technology, Inc. $TCMD Shares Purchased by LSV Asset ManagementMay 26, 2026 | marketbeat.comBTIG Remains a Buy on Tactile Systems Technology (TCMD)May 23, 2026 | theglobeandmail.comBTIG Research Reiterates Buy Rating for Tactile Systems Technology (NASDAQ:TCMD)May 21, 2026 | marketbeat.comUBS Group AG Sells 168,372 Shares of Tactile Systems Technology, Inc. $TCMDMay 21, 2026 | marketbeat.comTactile Medical to Present at the William Blair 46th Annual Growth Stock ConferenceMay 20, 2026 | globenewswire.comVanguard Group Inc. Boosts Position in Tactile Systems Technology, Inc. $TCMDMay 17, 2026 | marketbeat.comElaine Birkemeyer Sells 4,631 Shares of Tactile Systems Technology (NASDAQ:TCMD) StockMay 14, 2026 | insidertrades.comB Riley Securities upgrades Tactile Systems Technology (TCMD)May 8, 2026 | msn.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Just Released Its First-Quarter Earnings: Here's What Analysts ThinkMay 7, 2026 | finance.yahoo.comHealthcare Momentum Drives Interest In Tactile Systems Technology (NASDAQ:TCMD)May 6, 2026 | kalkinemedia.comKBTIG Keeps Their Buy Rating on Tactile Systems Technology (TCMD)May 6, 2026 | theglobeandmail.comPiper Sandler Sticks to Its Buy Rating for Tactile Systems Technology (TCMD)May 6, 2026 | theglobeandmail.comShould Value Investors Buy Tactile Systems Technology (TCMD) Stock?May 6, 2026 | zacks.comTactile Medical projects $360M-$368M 2026 revenue as Medicare prior authorization process maturesMay 5, 2026 | msn.comTactile Systems (TCMD) Q1 2026 Earnings TranscriptMay 5, 2026 | finance.yahoo.comTactile Systems Technology, Inc. (TCMD) Q1 2026 Earnings Call TranscriptMay 4, 2026 | seekingalpha.comTactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue EstimatesMay 4, 2026 | zacks.comTactile Systems Technology, Inc. Reports First Quarter 2026 Financial ResultsMay 4, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesCAVA Group’s Stock Looks Delicious After Strong EarningsBy Chris Markoch | May 22, 2026McDonald's Is the Cheapest It’s Been in Years—Does That Make It a Buy?By Sam Quirke | May 15, 20263 Ways to Play the Data Center Land GrabBy Nathan Reiff | May 31, 2026Slice of the Pie: Why Yum’s Deal Lifts QSRBy Jeffrey Neal Johnson | June 3, 2026Motorola's $1.5B Bet to Own the SkiesBy Jeffrey Neal Johnson | June 3, 2026TCMD, ESTA, AXGN, and LMAT Company DescriptionsAxoGen NASDAQ:AXGN$42.75 +0.39 (+0.92%) As of 01:09 PM Eastern This is a fair market value price provided by Massive. Learn more.AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.Establishment Labs NASDAQ:ESTA$82.27 -2.84 (-3.34%) As of 01:08 PM Eastern This is a fair market value price provided by Massive. Learn more.Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.LeMaitre Vascular NASDAQ:LMAT$92.79 +0.45 (+0.49%) As of 01:09 PM Eastern This is a fair market value price provided by Massive. Learn more.LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.Tactile Systems Technology NASDAQ:TCMD$26.44 +0.10 (+0.36%) As of 01:08 PM Eastern This is a fair market value price provided by Massive. Learn more.Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Boeing’s Unseen Rebound: Why the Headlines Are Wrong Why Oracle's 10% Drop May Be Telling the Wrong Story Spotify's "North Star" Outlook Was Music to Investors Ears DraftKings Hits the Jackpot With Super App Pivot Cracker Barrel Surges 23% as Earnings Beat Signals Turnaround Progress Microsoft Just Gave Investors 3 Dates They Can't Afford to Ignore SpaceX IPO Fears Are Overblown, But the AI Bet Is Real Applied Digital Is Building a $36 Billion AI Real Estate Empire Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
